Johnson Pharmacare Ltd — Board Meeting, 14-02-2026: Board Meeting
14-02-2026 | 06:06 pm
14-02-2026 | 06:06 pm
Johnson Pharmacare's board approved the financial results for the quarter and nine months ended 31st December 2025. The company reported a net loss of 0.06 Cr for the quarter with no operational revenue.
No comments yet. Be the first to comment!
